Adjuvant Global Health Technology Fund, L.P. - Insider Trading & Ownership
Entity
Company
Location
C/O Adjuvant Capital, L.P., 501 Fifth Avenue, Suite 1404, New York, NY
Summary
The estimated value of insider holdings of Adjuvant Global Health Technology Fund, L.P. is at least $45.4M dollars as of January 18, 2024. Adjuvant Global Health Technology Fund, L.P. is the 10%+ Owner of AN2 Therapeutics, Inc. and owns shares of AN2 Therapeutics, Inc. (ANTX) stock worth about $45.4M.
Insider Transactions Reported by Adjuvant Global Health Technology Fund, L.P.:
Sym
Company
Class
Transaction
%
Value $
* Price $
Shares
Shares After
Date
Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.